StockData
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31

Adagene Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$2.29+0.23 (+11.17%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Adagene Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Adagene does not break out revenue by segment, region or product in the tagged data of its filings for this period type.